Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
In a double-blind, dose-ranging, Phase IIa trial in 246 patients, a 125 mg dose of crofelemer met the endpoint of a significant improvement in pain score vs. placebo (p=0.02). The 125 mg dose did not ...